Universitätsklinikum Carl Gustav Carus Dresden

Hormonal Contraception. Guideline of the DGGG, OEGGG and SGGG (S3 Level, AWMF Registry Number 015/015, January 2020) (2021) Franik S, Bauersachs R, Beyer-Westendorf J, Buchholz T, Bühling K, Diener HC, Erath A, et al. Journal article Identification and purification of novel low-molecular-weight lupine allergens as components for personalized diagnostics (2021) Jappe U, Karstedt A, Warneke D, Hellmig S, Böttger M, Riffelmann FW, Treudler R, et al. Journal article Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial (2021) Kosmala R, Fokas E, Flentje M, Sauer R, Liersch T, Graeven U, Fietkau R, et al. Journal article A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS (2021) Maccari ME, Fuchs S, Kury P, Andrieux G, Bengsch B, Lorenz MR, Heeg M, et al. Journal article Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group (2021) Ostheimer C, Maeurer M, Ebert N, Schmitt D, Krug D, Baumann R, Henkenberens C, et al. Journal article Effect of plasma exchange on colchicine elimination in overdose–a case report (2021) Wacker M, Pietsch J, Okrojek R, Schmoll S, Hoppmann P, Laugwitz KL, Eyer F, Rabe C Journal article Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie – Update 2021 (2021) Ewig S, Kolditz M, Pletz M, Altiner A, Albrich W, Drömann D, Flick H, et al. Journal article, Review article Thirty-day outcomes of the Cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: The TriBAND study. (2021) Nickenig G, Friedrichs KP, Baldus S, Arnold M, Seidler T, Hakmi S, Linke A, et al. Journal article Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection (2021) Wagner KI, Mateyka LM, Jarosch S, Grass V, Weber S, Schober K, Hammel M, et al. Journal article, Original article Survival analysis of the randomised phase III GeparOcto trial comparing neoadjuvant chemotherapy of intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for patients with high-risk early breast cancer (2021) Schneeweiss A, Michel LL, Möbus V, Tesch H, Klare P, Hahnen E, Denkert C, et al. Journal article